Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michel Azizi

Showing results (71-80 of 267) with videos related to

Pageof 27
Sort By:
Clinical Physiology and Functional Imaging|February 2, 2010
Human in vivo study of the renin-angiotensin-aldosterone system and the sympathetic activity after 8 weeks daily intake of fermented milkLotte Usinger, Hans Ibsen, Allan Linneberg, et al.
Kidney International|June 14, 2013
Partial genetic deficiency in tissue kallikrein impairs adaptation to high potassium intake in humansJoana S Monteiro, Anne Blanchard, Emmanuel Curis, et al.
Journal of the American Society of Nephrology : JASN|May 25, 2001
Split renal function outcome after renal angioplasty in patients with unilateral renal artery stenosisAgnès LA Batide-Alanore, Michel Azizi, Marc Froissart, et al.
Hypertension (Dallas, Tex. : 1979)|April 24, 2013
Association of smoking with phenotype at diagnosis and vascular interventions in patients with renal artery fibromuscular dysplasiaSébastien Savard, Arshid Azarine, Xavier Jeunemaitre, et al.
Circulation|November 17, 2012
Association between 2 angiographic subtypes of renal artery fibromuscular dysplasia and clinical characteristicsSébastien Savard, Olivier Steichen, Arshid Azarine, et al.
Journal of Molecular Medicine (Berlin, Germany)|August 20, 2002
Functional consequences of angiotensin-converting enzyme gene polymorphism on N-acetyl-Ser-Asp-Lys-Pro degradation and angiotensin II productionMichel Azizi, Christophe Junot, Eric Ezan, et al.
Hypertension (Dallas, Tex. : 1979)|September 15, 2010
Aldosterone synthase inhibition with LCI699: a proof-of-concept study in patients with primary aldosteronismLaurence Amar, Michel Azizi, Joël Menard, et al.
Journal of the American College of Cardiology|September 25, 2013
First-in-man randomized clinical trial of renal denervation for atrial arrhythmia raises concernJan A Staessen, Yu Jin, Lutgarde Thijs, et al.
Journal of the American College of Cardiology|November 13, 2012
Eligibility for renal denervation in patients with resistant hypertension: when enthusiasm meets reality in real-life patientsSébastien Savard, Michael Frank, Guillaume Bobrie, et al.
Journal of Hypertension|September 11, 2021
Urine N-acetyl-Ser-Asp-Lys-Pro measurement as a versatile biomarker to assess adherence to angiotensin-converting enzyme inhibitorsBenjamin Kably, Eliane M Billaud, Audrey Derobertmasure, et al.
Pageof 27

Showing results (71-80 of 267) with videos related to

Sort By:
Pageof 27
Clinical Physiology and Functional Imaging|February 2, 2010
Human in vivo study of the renin-angiotensin-aldosterone system and the sympathetic activity after 8 weeks daily intake of fermented milkLotte Usinger, Hans Ibsen, Allan Linneberg, et al.
Kidney International|June 14, 2013
Partial genetic deficiency in tissue kallikrein impairs adaptation to high potassium intake in humansJoana S Monteiro, Anne Blanchard, Emmanuel Curis, et al.
Journal of the American Society of Nephrology : JASN|May 25, 2001
Split renal function outcome after renal angioplasty in patients with unilateral renal artery stenosisAgnès LA Batide-Alanore, Michel Azizi, Marc Froissart, et al.
Hypertension (Dallas, Tex. : 1979)|April 24, 2013
Association of smoking with phenotype at diagnosis and vascular interventions in patients with renal artery fibromuscular dysplasiaSébastien Savard, Arshid Azarine, Xavier Jeunemaitre, et al.
Circulation|November 17, 2012
Association between 2 angiographic subtypes of renal artery fibromuscular dysplasia and clinical characteristicsSébastien Savard, Olivier Steichen, Arshid Azarine, et al.
Journal of Molecular Medicine (Berlin, Germany)|August 20, 2002
Functional consequences of angiotensin-converting enzyme gene polymorphism on N-acetyl-Ser-Asp-Lys-Pro degradation and angiotensin II productionMichel Azizi, Christophe Junot, Eric Ezan, et al.
Hypertension (Dallas, Tex. : 1979)|September 15, 2010
Aldosterone synthase inhibition with LCI699: a proof-of-concept study in patients with primary aldosteronismLaurence Amar, Michel Azizi, Joël Menard, et al.
Journal of the American College of Cardiology|September 25, 2013
First-in-man randomized clinical trial of renal denervation for atrial arrhythmia raises concernJan A Staessen, Yu Jin, Lutgarde Thijs, et al.
Journal of the American College of Cardiology|November 13, 2012
Eligibility for renal denervation in patients with resistant hypertension: when enthusiasm meets reality in real-life patientsSébastien Savard, Michael Frank, Guillaume Bobrie, et al.
Journal of Hypertension|September 11, 2021
Urine N-acetyl-Ser-Asp-Lys-Pro measurement as a versatile biomarker to assess adherence to angiotensin-converting enzyme inhibitorsBenjamin Kably, Eliane M Billaud, Audrey Derobertmasure, et al.
Pageof 27